48HD is profiled as a top glycomics company in a new Glyconet report.

As with genomics 20 years ago, glycomics is at a critical stage, a tipping point. Glycomics is expected to generate explosive growth over the next decade in the biotechnology and pharma sectors.

GlycoNet has positioned Canada at the global forefront to deliver tangible, made-in-Canada solutions to pressing and emerging health and environmental challenges. GlycoNet is already supporting Canada’s One Health solutions and sustainable development. Their report highlights why the field of glycomics holds so much potential, why Canada is poised to lead this new frontier in bio-innovation, and why now is the time to take advantage of existing momentum to fully realize Canada’s potential as a global leader in glycomics.

Click here to read the report

Share This :

Recent Post

Discover your Ligands

We accelerate discovery to find new and better drugs leads in days rather than months.

Verified by MonsterInsights